Leaflet HIRUDOID gel 3mg / g

Product code:
W01842001
Quantity:
1
Indicated for:
prevention and treatment of thromboembolism
Route of administration:
cutaneous
Substance:
heparinoid (anticoagulant)
ATC
C05BA01 — Cardiovascular system | Antivaricose therapy | Heparins or heparinoids for topical use
Heparinoid in skin creams and gels is used to relieve superficial bruising, haematomas and inflammation of superficial veins. It has local effects on inflammation and swelling. It is not equivalent to injected heparin and does not replace treatment for deep vein thrombosis or pulmonary embolism.

Apply gently to intact skin in the amount and frequency stated in the leaflet. Avoid vigorous massage over a painful vein. Do not apply to open wounds, mucous membranes, sensitive areas or large surfaces. Wash hands afterwards and avoid eye contact. Follow the product's age limit rather than assuming every formulation is suitable for children.

Local sensitisation reactions, such as redness, itching or dermatitis, may occur. Some creams contain lanolin or preservatives that can cause allergy. Stop applying it if irritation increases. Unexplained or numerous bruises, particularly when taking anticoagulants, need assessment of their cause rather than topical treatment alone.

See a doctor if swelling enlarges, pain increases or symptoms fail to improve. Sudden painful swelling of one leg needs prompt assessment; associated breathlessness or chest pain is an emergency. During pregnancy, breastfeeding or use in children, check with a pharmacist that the chosen formulation is appropriate.

General data about HIRUDOID GEL 3mg / g

Substance:
heparinoid
Date of latest medicines list:
01-07-2013
Product code:
W01842001
Concentration:
3mg / g
Pharmaceutical form:
gel
Quantity:
1
Product type:
Original
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
STADA ARZNEIMITTEL AG - GERMANIA
Holder:
STADA ARZNEIMITTEL AG - GERMANIA
Number:
9773/2017/01
Shelf life:
5 years-after packing for marketing;after the first opening-1 year

Pharmaceutical forms available for heparinoid

Precautions:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk

This medicine may increase the risk of bleeding.